Among all analogs, BIIB021 represented one of the HSP90 inhibitors with the most efficacious activity and showed a high selectivity for tumor versus normal cells in the ERBB2 degradation assays with a pyridylmethylene group at the 9-position [157]. The gene discussed is HSP90AA1; the disease is neoplasm.